As MLL4 (KMT2D) loss of function mutations are among the most common events in human cancer, the results presented here offer a novel mechanism by which these mutations may promote both the initiation and progression of cancer, particularly in the setting of keratinocyte cancers, which collectively outnumber all other human malignancies (16). This evidence concerns the gene KMT2D and keratinocyte carcinoma.